Roughly 30,000 Americans are diagnosed with multiple myeloma each year—a rare but serious cancer of the plasma cells. Historically treated with chemotherapy, patients often faced recurring disease and…
Kidney cancer affects over 80,000 Americans annually, with renal cell carcinoma as the dominant type. Benjamin R. Lee, MD, MBA, outlines current AUA guideline recommendations, including when to…
Michael Benninger, MD, Chairman, Head and Neck Institute, Cleveland Clinic, discusses Wegener’s granulomatosis, the subglottic stenosis that often accompanies this disease, and the treatment challenges. Summary: 1. Wegener’s…
Michael Benninger, MD, Chairman, Head and Neck Institute, Cleveland Clinic, discusses the effects of herd immunization with pneumococcal vaccination. Summary: Community vaccination against pneumococcal disease has showed a…
NEW YORK (Reuters Health) – Even with its toxic effects, adjuvant chemotherapy improves quality-adjusted survival in patients with non-small-cell-lung cancer, according to a report in the Journal of…
Gary Falk, MD, MS, Professor of Medicine, Director, Center for Esophageal and Swallowing Disorders, Cleveland Clinic, discusses Barrett’s esophagus and its treatment in patients with dysplasia. Summary: 1.…
NEW YORK (Reuters Health) – In a study of childhood cancer survivors, treatment with total body or abdominal irradiation was associated with an increased risk of diabetes later…
NEW YORK (Reuters Health) – Having a first-degree relative with breast cancer may slightly increase a person’s risk of colorectal cancer, Canadian researchers report in the International Journal…
NEW YORK (Reuters Health) – Therapy with denosumab appears to augment bone mineral density and lower the risk of fracture among men with prostate cancer undergoing androgen-deprivation therapy,…
NEW YORK (Reuters Health) – Don’t assume that lower limb salvage yields better functional and quality-of-life outcomes than amputation for children and adolescents with bone and soft tissue…
NEW YORK (Reuters Health) – Ovarian- and uterine-conserving surgery appears to be safe in premenopausal women with stage IA or IC epithelial ovarian cancer, with no adverse impact…
NEW YORK (Reuters Health) – As first-line therapy for advanced chronic lymphocytic leukemia, bendamustine produced significantly higher response rates and longer progression-free survival than chlorambucil in a phase…
